1. Home
  2. ABCL vs NTCT Comparison

ABCL vs NTCT Comparison

Compare ABCL & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.22

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$37.88

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
NTCT
Founded
2012
1984
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
ABCL
NTCT
Price
$11.22
$37.88
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$8.40
$31.00
AVG Volume (30 Days)
9.1M
573.9K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
125.39
EPS
N/A
0.29
Revenue
$75,128,000.00
$891,820,000.00
Revenue This Year
N/A
$6.02
Revenue Next Year
$21.85
$2.55
P/E Ratio
N/A
$133.90
Revenue Growth
160.56
N/A
52 Week Low
$2.75
$24.37
52 Week High
$12.58
$45.28

Technical Indicators

Market Signals
Indicator
ABCL
NTCT
Relative Strength Index (RSI) 60.19 40.98
Support Level $10.44 $37.09
Resistance Level N/A $42.57
Average True Range (ATR) 0.78 0.90
MACD -0.08 0.04
Stochastic Oscillator 42.16 17.98

Price Performance

Historical Comparison
ABCL
NTCT

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About NTCT NetScout Systems Inc.

NetScout Systems Inc is engaged in providing enterprise network observability, carrier service assurance, cybersecurity, and Distributed Denial-of-Service (DDoS), protection solutions. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

Share on Social Networks: